Miist Therapeutics
PrivateLast Round
Seed
Feb 5, 2025
Total Funding Raised
$7M
Company Overview
Miist Therapeutics operates in Healthcare & Life Sciences and is based in Alameda, California. Its latest recorded funding round was a Seed round in February 2025.
Miist Therapeutics is a biotechnology company that develops inhaled therapies designed for rapid symptom relief using proprietary aerosol physics technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miist Therapeutics Comparables
Compare Miist Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qnovia | 81% | |
| Transpire Bio Inc. | 73% | |
| Pulmatrix, Inc. | 65% |
For institutional investors. Book with your work email.
Miist Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Miist Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| 1517 Fund | Seed |
| California Innovation Fund | Seed |
| Freeflow Ventures | Seed |
| Freeflow Ventures | Seed |
| Entrepreneurs First | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 430% MoM.
- Feb 5, 2025
$7M round completed.
For institutional investors. Book with your work email.
Miist Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Miist Therapeutics's valuation, stock price, and market status.
Is Miist Therapeutics a public or private company?
Miist Therapeutics is a private company.
What is the current stock price of Miist Therapeutics?
Miist Therapeutics is a private company, so its shares have no public market price. Caplight tracks Miist Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Miist Therapeutics worth (valuation)?
Valuation information for Miist Therapeutics is not publicly available.
Can I buy Miist Therapeutics stock?
Miist Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Miist Therapeutics's last funding round?
Miist Therapeutics's most recent funding round was Seed on February 5, 2025.
Who are the main investors in Miist Therapeutics?
Key investors in Miist Therapeutics include Refactor Capital.
Will Miist Therapeutics IPO soon?
No public IPO plans have been announced for Miist Therapeutics.
How can I track Miist Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Miist Therapeutics's shares on secondary markets.